Owner: Bio Saga URL:http://lukeskywaran.blogspot.com Join Date: Wed, 23 Jul 2008 06:54:47 -0500 Rating:0 Site Description: life science and informatics industry, trends, science, technology development, opportunities, news, products and services, companies, business models, trivia Site statistics:Click here
18 Ways to Improve your PubMed searches 2008-07-22 06:56:00 18 Ways to Improve
your PubMed searchesBe a part of the XTractor community. XTractor is the first of its kind - Literature alert service, that provides manually curated and annotated sentences for the Keywords of user preference. XTractor maps the extracted entities (genes, processes, drugs, diseases etc) to multiple ontologies and enables customized report generation. With XTractor the sentence
Launch of XTractor™ -a powerful scientific literature alert & abstraction system, now with unlimited free access. 2008-07-18 05:53:00 Bangalore, India — Indian Life Sciences Informatics Company, Molecular Connections announced today, the release of XTractor™, a first of its kind manually curated literature alert service. XTractor™ can be accessed free of charge by the scientific community world wide. XTractor™ acts as a literature alert service, which provides scientists with manually annotated scientific facts fr Read more:Launch
Sigma-Aldrich continues to make the Acta more useful and accessible to scientists around the world 2008-07-16 05:19:00 Sigma-Aldrich announced that its highly acclaimed chemistry review journal, Aldrichimica Acta, has again been ranked #1 by Impact Factor, out of 56 similar journals in the field of Organic Chemistry. In 2007, the latest year for which such rankings are available, the Acta achieved an Impact Factor of 11.929. The Acta was also ranked #1 in 2006 and 2005. These rankings appear annually in the Scienc Read more:scientists
, Sigma
Merck & Co., Pfizer, and Eli Lilly partnered with PureTech Ventures & form new firm called Enlight Biosciences 2008-07-14 06:48:00 Now this looks very interesting, three pharma big wigs getting together for something they have in common. The firm would cater to the niche requirement these pharmas have in the area of drug discovery. Enlight Biosciences will them the power to speed development of drug-discovery tools. The three pharmas and PureTech have ponied up a total of $39 million that Enlight will direct toward “brea Read more:Lilly
, Merck
, Pfizer
, Ventures
CNBC-TV18's Emerging India Award salutes best SME players 2008-07-09 05:04:00 Molecular Connections bagged the ‘Small Enterprise of the Year’ title. It was also the winner of the non-retail trade category.CNBC-TV18's Emerging IndiaAward
recognised the achievements of those SMEs (Small and Medium Enterprises), which dared to think global in a glittering function in London, on Tuesday.Microqual Techno - a company that provides microwave components to telecom operators wa Read more:salutes
THE ROLE OF PHYTOHORMONES TO ENHANCE THE EXPRESSION OF LIPID TRANSFER PROTEIN3 (LTP3) IN IMPROVING STAPLE LENGTH OF Gossypium hirsutum L. 2008-07-08 00:36:00 Here is a abstract that i had submitted at the Plant & Animal Genomes XI Conference January 11-15, 2003 Town & Country Convention Center San Diego, CA. I do not know how relevant is the issue to this day. If any one is interested or if any one is working in these lines, do let me know also pour in your suggestions and comments if any.Fiber quality in cotton is one very vital trait demandin
New antibiotic beats superbugs... 2008-07-07 02:31:00 The problem with antibiotics is that, eventually, bacteria outsmart them and become resistant. But by targeting the gene that confers such resistance, a new drug may be able to finally outwit them. Rockefeller University scientists tested the new drug, called Ceftobiprole, against some of the deadliest strains of multidrug-resistant Staphylococcus aureus (MRSA) bacteria, which are responsible for
Ranbaxy, others to scrap 60 drug combinations 2008-07-07 02:05:00 The country's leading drug makers, including Ranbaxy Laboratories, Cipla, Cadila Pharmaceuticals, Nicholas Piramal and Wockhardt, will soon withdraw about 60 drug combinations
from the market.The voluntary move comes a little more than a year after the Central Drugs Standard Control Organisation (CDSCO), the central authority that approves new drugs for marketing, had asked the drug makers to with
Molecular Connections to acquire firm in Europe 2008-07-03 23:35:00 The company provides database products to pharmaceutical companies for drug discovery and development. Betting big on the transition taking place in the global pharmaceutical industry, the company is now looking to grow through both inorganic and organic routes. Molecular
Connections is a joint venture between Idea2solutions, a venture capital arm promoted by the founders of Dr Reddy's group and a Read more:Europe
Singapore Attracts Life Science Companies 2008-06-30 07:38:00 Today, Singapore
continues to capitalize on its geographic location as one of the crossroads of the world to grow life science companies. About 70 airlines serve Singapore, making it a gateway to Southeast Asia.As a testament to their commitment to the life science industry in the 21st century, Singapore built two state-of-the-art biomedical research parks. The Biopolis, a biomedical research comp Read more:Companies
, Science
Novel therapies for age-related diseases such as Alzheimer's and Parkinson's 2008-06-30 01:45:00 In their current study, published in the online edition of the journal Nature, Conboy and her team found that old muscle produces elevated levels of a molecule called TGF-beta, which is known to inhibit muscle growth. The researchers then showed that the muscle-deteriorating effects of TGF-beta can be reversed by blocking its pathway in old mice. In the experiments, the researchers used RNA inter Read more:Alzheimer
, Parkinson
, related
Reading Between Lines 2008-06-27 06:33:00 In the series of blogs on the aftermath of GINA, first it was the consumers GINA Aftermath - Consumers Still Wary of Genetic Tests and now its the turn of the firms Gene Testing Questioned by Regulators , Consumer Genomics Firms Confused by California's Actions; State Seeks Federal Solution be is consumer or the firm no body is spared, as President Bush often quips "justice is served" and all are Read more:Lines
, Reading
CRANKITE: A fast polypeptide backbone conformation sampler 2008-06-26 06:53:00 Background: CRANKITE is a suite of programs for simulating backbone
conformations of polypeptides and proteins. The core of the suite is an efficient Metropolis Monte Carlo sampler of backbone conformations in continuous three-dimensional space in atomic details. Methods: In contrast to other programs relying on local Metropolis moves in the space of dihedral angles, our sampler utilizes local cra
The new beta version of UniProt 2008-06-26 04:49:00 Recently took a peek at the new version
of UniProt. It has some exciting features on customized searches, filtering results using key words, customize the results view and cross references to Public databases including the 3D- viewers. Try taking the SITE tour on the right hand side panel. This is a beta version
of the their new web site, most welcome to give your feedback. Please take i
Roche Acquires Early-Stage Cancer Drug In US$778mn Deal 2008-06-26 01:38:00 In keeping with Roche's commitment to developing cancer therapies, the company has acquired worldwide exclusive rights to an early stage cancer therapy that is being co-developed by Belgian biopharmaceutical firm Thrombogenics and Swedish antibody developer BioInvent. Under the agreement the two companies will share an upfront payment of EUR50mn (US$78mn) plus up to EUR450mn (US$700mn) based on re Read more:Cancer
, Early
, Stage
Controlling HIV Evolution 2008-06-25 07:57:00 Dr. Ronald Collman talks about exciting new discoveries on HIV, the virus that has taken 25 million lives. Dr. Ronald Collman, professor of medicine in microbiology, virus/cell/molecular core director, Penn Center for AIDS Research, University of Pennsylvania.He describes the molecular structure, pathology, and with great insight, the incredible discoveries that might just help us conquer HIV.List Read more:Controlling
, Evolution
XTRACTOR™ Data Mining Simplified 2008-06-18 07:32:00 The first of its kind - SCIENTIFIC LITERATURE alert service which also provides manually annotated sentences for the keywords of YOUR preference Highly accurate, manually annotated sentences for given keywords.Daily scientific literature updates at your desktop along with extracted facts - manually curated.Provision to change keywords with your changing research preferences.Annotated sentences an Read more:Data Mining
, Mining
GINA Aftermath - Consumers Still Wary of Genetic Tests 2008-06-18 06:46:00 Previously blogging on GINA Dawn of the GATTACA era! now Industry Survey Shows: The surveyors found that only five percent of consumers said that they were “very likely” to take a disease-specific genetic test in the next few years, and 15 percent said they would be “likely” to take one. A total of 35 percent said that they would not submit to genetic tests, with 14 percent citing concer Read more:Aftermath
Boehringer Ingelheim to Acquire Actimis Pharmaceuticals for $515M 2008-06-18 06:42:00 Boehringer Ingelheim will acquire Actimis Pharmaceuticals through a structured buyout in which Boehringer Ingelheim will acquire shares of Actimis depending on the achievement of several successive milestones with Actimis’ leading asthma compound AP768.If AP768, currently in Phase I development, is successfully advanced into a Phase III, Boehringer Ingelheim will own 100% of Actimis’ shares. U Read more:Acquire
Research Exposes New Target For Malaria Drugs 2008-08-07 06:32:00 The malaria parasite has waged a successful guerrilla war against the human immune system for eons, but a study in this week's Journal of Biological Chemistry has exposed one of the tricks malaria uses to hide from the immune proteins, which may aid in future drug development. Malaria parasites (plasmodia) are transmitted to people via infected mosquitoes. Once inside their human hosts the parasit Read more:Drugs
, Research
, Target
180 jobs to go at Pfizer in Cork 2008-08-07 06:24:00 180 jobs are to go in Cork after pharmaceutical giant Pfizer
announced it had failed to find a buyer for one of its five manufacturing facilities in Ireland. For the past 18 months, the company had been actively trying to sell the facility at Little Island as a going concern and retain employment there. However the sale fell through last month and the company says the facility will now closed by t
Roche tipped to be world's top drugmaker by 2014 2008-08-07 01:39:00 Switzerland's Roche Holding AG is set to become the world's biggest drugmaker by sales in 2014, as current market leader Pfizer Inc skids down the rankings to sixth place, according to a study on Monday. The realignment of the global drugs industry reflects the looming "cliff" of patent expiries, which will see many of the world's top-selling medicines cannibalized by cheap generics over the next
The goal should be to teach students how to think and not how to work at a bench. 2008-08-05 05:02:00 Here a very noble thought "Science programs often pretend to be career oriented but they should be knowledge oriented. The main goal should be to teach students how to think
and not how to work at a bench. Thus, students who graduate from an undergraduate—or graduate—program will have valuable skills that they can use in any career they choose." Brought out really well in this blog article ch
Recommend Site To A Friend
